BioSpace News Archive

Innovative program will provide critical capabilities and help accelerate global scaling of Canadian sector

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, and a subsidiary of Grifols, announced today publication of research, titled, “Single cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironment,” in the peer-reviewed journal BMC Biology

Exacis Biotherapeutics Inc., a development-stage immuno-oncology company working to democratize access to the most advanced and effective cancer treatments, revealed key data related to its engineered iPSC-derived NK-cell platform at the American Society of Gene & Cell Therapy 24th Annual Meeting

Non-specific degradation of endocytosed cancer antigens by endo-lysosomal organelles in dendritic cells (DCs) is a major limitation in the field of cancer vaccination.

The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s Psilocybin-For-Neuropsychiatric Disorder (PFN(TM)) program

Medtronic plc, the global leader in medical technology, announced it will participate virtually in the following upcoming investor conferences

Infinity BiologiX, a next-generation central laboratory, announced a $50,000 donation to Sewa International and UNICEF USA to assist with on-the-ground humanitarian relief in India, following the deadly surge in COVID-19 infections.

LeMaitre, a provider of vascular devices, implants and services, announced that it received CE marks under the European Medical Devices Directive for the following five products.

AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced that co-founder and CEO Dr. Moonsoo Jin was awarded a Research Project Grant.

The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center participated in a clinical study to evaluate the safety and effectiveness of a new lattice sphere catheter designed to optimize procedural efficiency and efficacy across a broad range of cardiac arrhythmias.